Integra LifeSciences [IART] vs Establishment Labs [ESTA] Detailed Stock Comparison

Integra LifeSciences Holdings Corporation

NASDAQ
Loading...

Establishment Labs Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Integra LifeSciences Holdings Corporation wins in 14 metrics, Establishment Labs Holdings Inc. wins in 5 metrics, with 0 ties. Integra LifeSciences Holdings Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Integra LifeSciences Holdings Corporation Establishment Labs Holdings Inc. Better
P/E Ratio (TTM) 66.48 -37.89 Integra LifeSciences Holdings Corporation
Price-to-Book Ratio 0.79 79.68 Integra LifeSciences Holdings Corporation
Debt-to-Equity Ratio 195.01 1,123.15 Integra LifeSciences Holdings Corporation
PEG Ratio -0.61 0.41 Establishment Labs Holdings Inc.
EV/EBITDA 8.70 -70.21 Integra LifeSciences Holdings Corporation
Profit Margin (TTM) -31.58% -24.19% Establishment Labs Holdings Inc.
Operating Margin (TTM) 12.44% -6.08% Integra LifeSciences Holdings Corporation
EBITDA Margin (TTM) 12.44% N/A N/A
Return on Equity -39.90% -133.25% Integra LifeSciences Holdings Corporation
Return on Assets (TTM) 2.39% -6.93% Integra LifeSciences Holdings Corporation
Free Cash Flow (TTM) $-45.25M $-57.61M Integra LifeSciences Holdings Corporation
1-Year Return 26.70% 105.37% Establishment Labs Holdings Inc.
Price-to-Sales Ratio (TTM) 0.50 8.92 Integra LifeSciences Holdings Corporation
Enterprise Value $2.59B $2.07B Integra LifeSciences Holdings Corporation
EV/Revenue Ratio 1.58 9.79 Integra LifeSciences Holdings Corporation
Gross Profit Margin (TTM) 50.78% 70.46% Establishment Labs Holdings Inc.
Revenue per Share (TTM) $21 $7 Integra LifeSciences Holdings Corporation
Earnings per Share (Diluted) $-6.74 $-1.72 Establishment Labs Holdings Inc.
Beta (Stock Volatility) 1.07 1.08 Integra LifeSciences Holdings Corporation
Short % of Float 15.66% 22.26% Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation vs Establishment Labs Holdings Inc. Stock Performance Analysis

Loading Price Chart...

IART
ESTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Integra LifeSciences Holdings Corporation2.74%5.99%51.17%52.46%19.35%34.05%
Establishment Labs Holdings Inc.2.84%1.53%3.09%1.83%6.86%5.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Integra LifeSciences Holdings Corporation26.70%-58.81%-76.26%-57.80%-32.49%-15.84%
Establishment Labs Holdings Inc.105.37%6.40%-6.53%167.87%167.87%167.87%

Performance & Financial Health Analysis: Integra LifeSciences Holdings Corporation vs Establishment Labs Holdings Inc.

MetricIARTESTA
Market Information
Market Cap i$804.31M$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i754,949451,437
90 Day Avg. Volume i818,793478,309
Last Close$16.10$72.41
52 Week Range$8.70 - $16.70$33.35 - $83.31
% from 52W High-3.59%-13.08%
All-Time High$77.40 (Apr 26, 2021)$93.80 (Apr 18, 2022)
% from All-Time High-79.20%-22.80%
Growth Metrics
Quarterly Revenue Growth-0.02%0.45%
Quarterly Earnings Growth-0.02%0.45%
Financial Health
Profit Margin (TTM) i-0.32%-0.24%
Operating Margin (TTM) i0.12%-0.06%
Return on Equity (TTM) i-0.40%-1.33%
Debt to Equity (MRQ) i195.011,123.15
Cash & Liquidity
Book Value per Share (MRQ)$13.40$0.80
Cash per Share (MRQ)$3.38$2.58
Operating Cash Flow (TTM) i$50.38M$-50,890,000
Levered Free Cash Flow (TTM) i$44.46M$-41,574,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Integra LifeSciences Holdings Corporation vs Establishment Labs Holdings Inc.

MetricIART (Apr 24, 2026)ESTA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i66.48-37.89
Forward P/E i4.11316.35
PEG Ratio i-0.610.41
Price to Sales (TTM) i0.508.92
Price to Book (MRQ) i0.7979.68
Market Capitalization
Market Capitalization i$804.31M$1.91B
Enterprise Value i$2.59B$2.07B
Enterprise Value Metrics
Enterprise to Revenue i1.589.79
Enterprise to EBITDA i8.70-70.21
Risk & Other Metrics
Beta i1.071.08
Book Value per Share (MRQ) i$13.40$0.80

Financial Statements Comparison: Integra LifeSciences Holdings Corporation vs Establishment Labs Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIART (2025)ESTA (2025)
Revenue/Sales i1.64B211.08M
Cost of Goods Sold i803.63M64.77M
COGS % of Revenue i49.1%30.7%
Gross Profit i831.62M146.31M
Gross Margin i50.9%69.3%
Research & Development i98.97M20.25M
Operating Income (EBIT) i18.00M-39.01M
Operating Margin i1.1%-18.5%
EBITDA i185.95M-22.29M
EBITDA Margin i11.4%-10.6%
Pre-Tax Income i-563.50M-58.02M
Pre-Tax Income % of Revenue i-34.5%-27.5%
Income Tax i-47.03M-6.96M
Income Tax % of Revenue i-2.9%-3.3%
Net Income (Profit) i-516.47M-51.06M
Profit Margin i-31.6%-24.2%

Balance Sheet & Liquidity Metrics

MetricIART (2025)ESTA (2025)
Cash & Equivalents i235.05M75.57M
Total Current Assets i1.16B249.94M
Total Current Assets % of Revenue i70.9%118.4%
Total Current Liabilities i455.98M82.14M
Total Current Liabilities % of Revenue i27.9%38.9%
Long-Term Debt i1.89B250.34M
Long-Term Debt % of Revenue i115.7%118.6%
Total Shareholders Equity i1.04B23.55M
Retained Earnings i423.44M-495.76M
Retained Earnings % of Revenue i25.9%-234.9%
Property, Plant & Equipment i140.57M4.34M

Cash Flow Statement Comparison

MetricIART (2025)ESTA (2025)
Operating Cash Flow i-458.67M-50.78M
Operating Cash Flow % of Revenue i-28.0%-24.1%
Capital Expenditures i-81.44M-6.05M
Free Cash Flow i-45.25M-57.61M
FCF Margin i-2.8%-27.3%
Debt Repayment i-669.89M-1.02M
Common Stock Repurchase i-221,000N/A

Short Interest & Institutional Ownership Analysis

MetricIARTESTA
Shares Short i8.86M5.22M
Short Ratio i10.739.90
Short % of Float i15.66%22.26%
Shares Outstanding i77.89M29.30M
Float Shares i58.96M19.22M
% Held by Insiders i14.38%10.16%
% Held by Institutions i97.96%102.08%
% Held by Public i-12.34%-12.24%

Dividend Analysis & Yield Comparison: Integra LifeSciences Holdings Corporation vs Establishment Labs Holdings Inc.

MetricIARTESTA
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A